'Luoxin' Honored as 'Famous Chinese Trademark' and Rated as '2008 Top 100 Pharmaceutical Companies in China'

Shandong Luoxin Pharmacy Stock Co., Ltd. ("Luoxin Pharma" or the "Company", stock code: 8058), one of the leading PRC pharmaceutical enterprises, announced today that its "Luoxin" brand has been endorsed as a "Famous Chinese Trademark" by the State Administration for Industry and Commerce of the PRC. In addition, the Company was also rated as one of the "Top Ten Pharmaceutical Enterprises with Growth Potential" and "Top 100 Pharmaceutical Companies in China" for three consecutive years, moving up by 4 places to rank 63rd on the list, further strengthening the brand image of the Company.

Mr. Liu Baoqi, Chairman of Luoxin Pharma, said, "We are honored to receive these prestigious awards this year. With our dedicated efforts being placed in the research and development over the years, Luoxin brand is now synonymous with high quality and reliability. With the "Shandong's Famous Trademark" and now endorsed as a "Famous Chinese Trademark", the awards have not only recognized the Company's leading position in the industry, but also further enhanced its brand's image. In the future, we will continue to dedicate additional resources toward enhancing our research and development capacities to provide more high value-added products and strengthen our product portfolio, in an effort of rewarding the society with high quality products."

"Top 100 Pharmaceutical Companies in China" was announced during PHARMCHINA China National Pharmaceuticals Fair, the criteria was based on the production scale and growth rate of the enterprises, new criteria for this year namely corporate social responsibility, brands, corporate culture, management structure and sales network, selected 100 pharmaceutical companies from 4,738 enterprises.

About Luoxin Pharma

Luoxin Pharma has been listed on the GEM of the Stock Exchange of Hong Kong Limited since 9 December 2005. The Company was recognized as one of the "Top Ten Pharmaceutical Enterprises with Growth Potential" and named as one of the "Top 100 Pharmaceutical Companies in China" since 2006. It was also honored as one of the 200 "Small and Medium-sized Enterprises in China with Most Potentials" by Forbes for two consecutive years. The Company is principally engaged in the development, manufacturing and sale of different types of prescription and OTC (over-the-counter) medicines in 4 major categories: 1) antibiotics, including Cephalosporines antibiotics, Quinolones antibiotics and Macrolides antibiotics; 2) anti-viral medicines; 3) system-specific medicines, including digestive system medicines, cardiovascular system medicines and respiratory system medicines; 4) other chemical medicines, including Antineoplastic medicines. The Company's production facilities are located in the High and New Technology Experimental Zone, Linyi, Shandong Province, the PRC, and has obtained all required production permits as well as GMP certification. Its sales and marketing networks cover 27 provinces and 4 municipalities in the PRC. Please visit www.luoxin.cn.

Source: Luoxin Pharma

Contact: Ms. Kelly Fung
Tel: +852 3150 6763
kelly.fung@pordafinance.com.hk

Ms. Kate Lam
Tel: +852 3150 6738
kate.lam@pordafinance.com.hk

Ms. Susanna Ho
Tel: +852 3150 6755
susanna.ho@pordafinance.com.hk

Fax: +852 3150 6728

Related terms: cardiovascular, china, commerce, corporate, hong kong, manufacturing, marketing, otc, pharmaceuticals, products, research and development, respiratory, sales, shandong